King Luther Capital Management Corp decreased its stake in Salesforce Inc. by 9.2% in the fourth quarter of 2025, selling 24,691 shares and retaining 244,175 shares valued at $64.7 million. Despite this reduction, institutional ownership of Salesforce remains high at 80.43%, with several other firms significantly increasing their positions. Analysts generally rate Salesforce as a "Moderate Buy" with a consensus target price of $274.12, following strong quarterly results and a $25 billion share repurchase program.

King Luther Capital Management Corp decreased its stake in Teledyne Technologies Incorporated by 1.2% in the fourth quarter, selling 6,420 shares. Despite this, Teledyne Technologies remains a significant holding for the firm, representing 1.1% of its investment portfolio. Other institutional investors, however, generally increased their holdings in TDY during the same period.

Knights of Columbus Asset Advisors LLC significantly increased its stake in Cisco Systems, Inc. during the fourth quarter, purchasing an additional 19,345 shares to bring its total holding to 277,951 shares valued at approximately $21.41 million. This increase reflects growing optimism around Cisco due to strong quarterly earnings, a dividend announcement, and positive analyst revisions citing increased demand from AI infrastructure. The company has also seen insider selling, though institutional ownership remains high at 73.33%.

William Blair Investment Management LLC significantly increased its stake in Motorola Solutions, Inc. by 606.8% in Q4, now holding 20,532 shares valued at approximately $7.87 million. Motorola Solutions reported strong Q1 results, exceeding EPS and revenue expectations, and raised its Q2 and full-year 2026 guidance. The company also announced a quarterly dividend of $1.21 per share and maintains a "Buy" average analyst rating with a consensus price target of $504.67.

King Luther Capital Management Corp significantly increased its stake in Netflix, Inc. (NFLX) by 1,173.7% in the fourth quarter, amassing 1.78 million shares valued at approximately $167.1 million. This comes as Netflix reported strong quarterly earnings, surpassing analyst estimates with $1.23 EPS and $12.25 billion in revenue. Despite solid fundamentals and positive analyst sentiment, the stock recently saw a 1.0% decline, and insiders have been actively selling shares.

AT&T announced it will webcast a fireside chat with CFO Pascal Desroches at the 2026 Mizuho Technology Conference on June 9, 2026, at 9:00 a.m. ET. The company reiterated its 2026 and multi-year financial and operational guidance, including improved growth in adjusted EBITDA and EPS, higher free cash flow through 2028, and a commitment to return over $45 billion to shareholders. AT&T also maintains its second-quarter 2026 expectations for increased wireless service revenue, consolidated adjusted EBITDA, and free cash flow between $4.0 and $4.5 billion.

Knights of Columbus Asset Advisors LLC reduced its stake in American Tower Corporation (AMT) by 20.7% in the fourth quarter, selling 16,330 shares and retaining 62,597 shares valued at $10.99 million. American Tower reported strong quarterly earnings, exceeding estimates, and raised its FY 2026 guidance. The company also declared a quarterly dividend of $1.79 per share, contributing to an annualized yield of 3.9%, and maintains a "Moderate Buy" consensus rating from analysts with an average price target of $216.20.

MaxLinear (Nasdaq: MXL) and GCT Semiconductor (NYSE: GCTS) have announced a strategic partnership to develop advanced 5G fixed wireless access (FWA) and converged gateways for consumer and enterprise use. This collaboration aims to provide highly integrated, cost-effective, and high-performance internet solutions, leveraging their combined expertise in Wi-Fi, network processing, and cellular technologies. The integrated solutions will be showcased at Computex Taipei, highlighting their efforts to address the growing demand for high-speed broadband and resilient multi-WAN connectivity.

NRx Pharmaceuticals' subsidiary, HOPE Therapeutics, has become the first commercial site to deploy Zeta Surgical's FDA-cleared Zeta TMS Navigation System at its West Palm Beach clinic. This AI-guided platform provides sub-millimetric, image-guided Transcranial Magnetic Stimulation (TMS) for major depressive disorder and other neurological conditions, enhancing HOPE's interventional psychiatry network. The deployment also aligns with a planned clinical trial combining NRX-101 with robotic-enabled TMS for depression and suicidality.

NRx Pharmaceuticals' subsidiary, HOPE Therapeutics, has become the first commercial site to implement Zeta Surgical's FDA-cleared Zeta TMS Navigation System at its West Palm Beach clinic. This system offers AI-powered, sub-millimetric image guidance for Transcranial Magnetic Stimulation (TMS) therapy, targeting patients with Major Depressive Disorder and other neurological conditions. The deployment supports HOPE's interventional psychiatry platform and NRx's plans for a clinical trial combining NRX-101 with robotic-enabled TMS for severe depression and suicidality.